AG-PD

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAG-PD
Drug Alias Nameundisclosed lentiviral gene therapy (American Gene Technologies)AG-PD
ClassificationBiologics
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 modulators
TargetsPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmerican Gene Technologies International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmerican Gene Technologies International Inc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A